XML 52 R30.htm IDEA: XBRL DOCUMENT v3.22.1
Share-Based Compensation
12 Months Ended
Jan. 29, 2022
Share-Based Compensation [Abstract]  
Share-Based Compensation

21. Share-Based Compensation

Stock Awards

Under our 2007 Stock Incentive Plan (the “2007 Stock Plan”), stock options, restricted stock, restricted stock units, stock appreciation rights, or other share-based awards may be granted to nonemployee directors, officers and other employees, including our subsidiaries and operating divisions worldwide. Options for employees become exercisable in substantially equal annual installments over a three-year period, beginning with the first anniversary of the date of grant of the option, unless a shorter or longer duration is established at the time of the option grant. The options terminate ten years from the date of grant. On May 21, 2014, the 2007 Stock Plan was amended to increase the number of shares of common stock reserved for all awards to 14 million shares. As of January 29, 2022, there were 5,714,498 shares available for issuance under this plan.

Employees Stock Purchase Plan

Under our 2013 Foot Locker Employees Stock Purchase Plan (“ESPP”), participating employees are able to contribute up to 10% of their annual compensation, not to exceed $25,000 in any plan year, through payroll deductions to acquire shares of our common stock at 85% of the lower market price on one of two specified dates in each plan year. Of the 3,000,000 shares of common stock authorized under this plan, there were 1,974,376 shares available for purchase as of January 29, 2022. During 2021 and 2020, participating employees purchased 300,788 shares and 104,054 shares, respectively.

Share-Based Compensation Expense

Total compensation expense included in SG&A and the associated tax benefits recognized related to our share-based compensation plans, were as follows:

($ in millions)

2021

    

2020

    

2019

Options and shares purchased under the stock purchase plan

$

6

$

6

$

6

Restricted stock units and performance stock units

 

23

 

9

 

12

Total share-based compensation expense

$

29

$

15

$

18

Tax benefit recognized

$

3

$

2

$

2

Valuation Model and Assumptions

The Black-Scholes option-pricing model is used to estimate the fair value of share-based awards. The Black-Scholes option-pricing model incorporates various and subjective assumptions, including expected term and expected volatility.

We estimate the expected term of share-based awards using our historical exercise and post-vesting employment termination patterns, which we believe are representative of future behavior. The expected term for the employee stock purchase plan valuation is based on the length of each purchase period as measured at the beginning of the offering period, which is one year.

We estimate the expected volatility of our common stock at the grant date using a weighted-average of our historical volatility and implied volatility from traded options on our common stock. We believe that this combination of historical volatility and implied volatility provides a better estimate of future stock price volatility.

The risk-free interest rate assumption is determined using the Federal Reserve nominal rates for U.S. Treasury zero-coupon bonds with maturities similar to those of the expected term of the award being valued. The expected dividend yield is derived from our historical experience.

The following table shows the assumptions used to compute the share-based compensation expense:

Stock Option Plans

Stock Purchase Plan

 

2021

    

2020

    

2019

    

2021

    

2020

    

2019

 

Weighted-average risk free rate of interest

0.9

%  

0.5

%  

2.2

%  

0.1

%  

1.8

%  

2.2

%

Expected volatility

47

%  

37

%  

38

%  

45

%  

48

%  

54

%

Weighted-average expected award life (in years)

5.5

 

4.9

 

5.5

 

1.0

 

1.0

 

1.0

Dividend yield

1.5

%  

4.3

%  

2.6

%  

4.0

%  

4.2

%  

3.1

%

Weighted-average fair value

$

20.22

$

5.03

$

17.07

$

9.61

$

13.97

$

16.68

The information set forth in the following table covers options granted under our stock option plans:

    

    

Weighted-

    

Weighted-

Number

Average

Average

of

Remaining

Exercise

Shares

Contractual Life

Price

(in thousands)

(in years)

(per share)

Options outstanding at the beginning of the year

 

3,540

 

$

47.17

Granted

 

183

 

 

53.82

Exercised

 

(311)

 

 

33.28

Expired or cancelled

 

(201)

 

 

47.93

Options outstanding at January 29, 2022

 

3,211

 

4.8

$

48.84

Options exercisable at January 29, 2022

 

2,472

 

3.7

$

53.70

The total fair value of options vested was $4 million and $6 million during 2021 and 2020. During the year ended January 29, 2022, we received $10 million in cash from option exercises and recognized a related tax benefit of $2 million.

The total intrinsic value of options exercised (the difference between the market price of the Company’s common stock on the exercise date and the price paid by the optionee to exercise the option) is presented below:

($ in millions)

2021

2020

2019

Exercised

$

8

$

3

$

5

The aggregate intrinsic value for stock options outstanding, and those outstanding and exercisable (the difference between the closing stock price on the last trading day of the period and the exercise price of the options, multiplied by the number of in-the-money stock options) is presented below:

($ in millions)

2021

Outstanding

$

20

Outstanding and exercisable

$

8

As of January 29, 2022, there was $2 million of total unrecognized compensation cost related to nonvested stock options, which is expected to be recognized over a remaining weighted-average period of 1.4 years.

The following table summarizes information about stock options outstanding and exercisable at January 29, 2022:

Options Outstanding

Options Exercisable

Weighted-

Average

Weighted-

Weighted-

Remaining

Average

Average

Range of Exercise

Number

Contractual

Exercise

Number

Exercise

Prices

    

Outstanding

    

Life

    

Price

    

Exercisable

    

Price

 

(in thousands, except prices per share and contractual life)

$21.60 - $36.51

 

965

6.2

$

23.91

 

467

$

26.32

$44.78 - $48.98

 

471

3.7

 

45.01

 

471

 

45.01

$53.61 - $58.94

 

523

6.5

 

56.71

 

282

 

57.94

$62.02 - $72.83

1,252

3.4

 

66.23

 

1,252

 

66.23

 

3,211

 

4.8

$

48.84

 

2,472

$

53.70

Restricted Stock Units and Performance Stock Units

Restricted stock units (“RSU”) may be awarded to certain officers, key employees of the Company, and nonemployee directors. Additionally, performance stock units (“PSU”) are awarded to officers and certain key employees in connection with our long-term incentive program. Each RSU and PSU represents the right to receive one share of our common stock provided that the applicable performance and vesting conditions are satisfied.

Generally, RSU awards fully vest after the passage of time, typically three years for employees and one year for nonemployee directors, provided there is continued service with the Company until the vesting date, subject to the terms of the award. PSU awards are earned only after the attainment of performance goals in connection with the relevant performance period and vest after an additional one-year period. No dividends are paid or accumulated on any RSU or PSU awards.

Compensation expense is recognized using the market value at the date of grant and is amortized over the vesting period, provided the recipient continues to be employed. RSU and PSU activity is summarized as follows:

Weighted-Average

Number

Remaining

Weighted-Average

of

Contractual

Grant Date

Shares

Life

Fair Value

    

(in thousands)

    

(in years)

    

(per share)

Nonvested at beginning of year

 

1,348

 

$

38.48

Granted

 

450

 

 

54.28

Vested

 

(523)

 

 

43.58

Performance adjustment (1)

240

Forfeited

 

(124)

 

 

39.49

Nonvested at January 29, 2022

 

1,391

 

1.5

$

43.95

Aggregate value ($ in millions)

$

61

 

  

 

(1)This represents adjustments made to PSU awards reflecting changes in estimates based upon our current performance against predefined financial targets.

The total fair value of awards vested was $23 million, $6 million, and $5 million, for 2021, 2020, and 2019, respectively. At January 29, 2022, there was $33 million of total unrecognized compensation cost related to nonvested awards.